Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight

The cell and gene therapy CDMO market is projected to grow from USD 8.3 billion in 2025 to USD 57.1 billion by 2034, driven by increasing clinical development of advanced therapies, rising outsourcing trends among biopharma companies, and technological advancements in manufacturing. North America leads the market with 40% share, while Asia-Pacific emerges as a significant growth hub. Key players are expanding manufacturing capabilities through strategic partnerships.

06/18/2026, 1:00 PM • GlobeNewswire

Is WuXi AppTec's Buyback Campaign Working Amid Mounting US Pressure?

WuXi AppTec launched a HK$1.26 billion buyback campaign to shore up its share price amid sector weakness and geopolitical headwinds. However, the company's stock fell over 5% after the U.S. Department of Defense designated it as a military-linked company on June 8, raising compliance concerns for its major multinational clients. Despite solid fundamentals with a 23.6% year-on-year increase in order backlog, the company faces significant policy uncertainty that may be overpriced into its current valuation.

06/11/2026, 9:07 AM • Benzinga

China's Tech Giants Alibaba, Baidu, BYD Face Fresh US Scrutiny As Pentagon Expands Blacklist

The Pentagon has expanded its 1260H list to include major Chinese tech companies Alibaba, Baidu, and BYD, along with others like WuXi AppTec, RoboSense, and BOE Technology Group, citing suspected ties to China's military and defense-industrial sector. While no immediate sanctions apply, the Defense Department will be prohibited from contracting with these companies starting later this month and from procuring their products through third parties by June 2027. Some companies have challenged their inclusion and plan to seek removal.

06/09/2026, 3:11 AM • Benzinga

Novel Gastric Drug Hopes Fuel Strong Hong Kong Debut For Biotech Firm

TenNor Therapeutics achieved a stellar Hong Kong IPO debut with a 179% first-day surge, driven by investor enthusiasm for its novel anti-bacterial drug rifasutenizol targeting helicobacter pylori infections. The offering was oversubscribed 9,000 times in Hong Kong and raised approximately $76 million. Despite strong market reception, the company remains unprofitable with cumulative losses exceeding 490 million yuan over three years, with approval expected by end of 2026.

05/28/2026, 9:29 AM • Benzinga

Cell Banking Outsourcing Market: 16%+ CAGR (2026-2031), Expanding with Rising Demand for Biologics and Regenerative Medicine Services, Says Mordor Intelligence

The cell banking outsourcing market is projected to grow from USD 16.78 billion in 2025 to USD 42.31 billion by 2031, with a CAGR of 16.71%. Growth is driven by increasing demand for biologics, cell and gene therapies, and regenerative medicine. North America leads the market while Asia-Pacific emerges as a high-growth region. Biopharmaceutical companies are increasingly outsourcing cell banking operations to improve efficiency and reduce costs.

05/25/2026, 4:15 AM • GlobeNewswire

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

The global protein synthesis research market is experiencing accelerating growth driven by increased investment in cell and gene therapy research, rising chronic disease prevalence, and expanding healthcare budgets. North America leads with 42.8% market share, while Asia-Pacific infrastructure expansion presents significant growth opportunities. Key market drivers include strong late-stage therapy pipelines and government support through initiatives like the CHIPS and Science Act.

05/18/2026, 2:33 PM • GlobeNewswire

Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight

The plasmid DNA manufacturing market is projected to grow from USD 2.4 billion in 2025 to USD 10.8 billion by 2034, driven by rising demand for gene therapies, DNA vaccines, and CAR-T treatments. North America leads the market with 44.12% share, while Asia-Pacific emerges as a significant growth engine. Major companies are expanding GMP-compliant manufacturing capabilities to meet increasing demand from biopharmaceutical companies and CDMOs.

05/04/2026, 1:00 PM • GlobeNewswire

Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

The drug development services market is projected to grow from $28.09 billion in 2025 to $50.26 billion by 2030 at a CAGR of 12.4%, driven by increased R&D investments, AI adoption, personalized medicine, and emerging market expansion. Key growth areas include preclinical research, regulatory optimization, and cloud-based data management, with precision medicine and genomics advancements playing pivotal roles.

04/14/2026, 10:59 AM • GlobeNewswire

[Latest] Global Adeno Associated Virus Vector Manufacturing Market Size/Share Worth USD 9.87 Billion by 2035 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)

The global Adeno Associated Virus (AAV) vector manufacturing market is projected to grow from USD 2.84 billion in 2025 to USD 9.87 billion by 2035, at a CAGR of 13.4%. Growth is driven by increased clinical trials, regulatory approvals of AAV-based gene therapies, technological innovations in manufacturing processes, and rising demand from pharmaceutical companies and CDMOs. North America leads the market while Asia Pacific shows the fastest growth rate.

02/03/2026, 1:00 PM • GlobeNewswire

Small Molecule Healthcare Contract Manufacturing Market Trends Analysis Report 2025-2033: Growing Demand for Advanced CMOs Specializing in HPAPIs and Complex Formulations

The global small molecule healthcare contract manufacturing market is projected to grow from USD 109.04 billion in 2024 to USD 310.6 billion by 2033, with a CAGR of 12.56%. Growth is driven by increased pharmaceutical outsourcing, demand for cost-efficient production, rising small molecule therapeutics for chronic diseases, and specialized capabilities in HPAPIs and complex formulations.

01/19/2026, 10:56 AM • GlobeNewswire

Bioanalytical Services Market Projected to Reach US$ 11.61 Billion by 2035, Driven by Rising FDA Approvals and Clinical Trial Activity Says Astute Analytica

The global bioanalytical services market is expected to grow from US$ 3.96 billion in 2025 to US$ 11.61 billion by 2035 at a CAGR of 11.6%. Growth is driven by FDA Modernization Act 2.0 implementation, increased clinical trial activity, and a shift toward advanced testing methodologies like cell-based assays and LC-MS/MS platforms. Cell-based assays lead with 46.1% market share, while small molecules account for 55.4%. Oncology applications dominate at 32% share, driven by the explosive pipeline of 1,200+ Antibody-Drug Conjugates.

01/05/2026, 1:00 PM • GlobeNewswire

Lead Optimization Services in Drug Discovery Market to Reach USD 10.26 Billion by 2034, Driven by Rising R&D Activity

The global lead optimization services in drug discovery market is projected to grow from USD 4.26 billion in 2024 to USD 10.26 billion by 2034, driven by rising R&D activities, technological advancements, and increasing outsourcing trends in pharmaceutical research.

11/28/2025, 10:00 AM • GlobeNewswire

Innovative Drug CRO Market to Soar USD 96.06 Billion by 2035, Expanding at 5.44% CAGR

The global innovative drug CRO market is projected to grow from USD 59.63 billion in 2026 to USD 96.06 billion by 2035, with a 5.44% CAGR, driven by increasing R&D costs, clinical trial complexities, and technological advancements.

11/28/2025, 9:00 AM • GlobeNewswire

China's Corporate Pivots: Alibaba's Food Delivery Gambit and WuXi AppTec's Geopolitical Hedge

Two major Chinese companies are strategically repositioning: Alibaba is rebranding its food delivery service under Taobao to expand instant commerce capabilities, while WuXi AppTec is exploring manufacturing in Saudi Arabia to mitigate U.S.-China trade tensions.

11/19/2025, 8:21 AM • Benzinga

CDMO Services Market for Pharma and Biotech: Growth Outlook and Industry Insights (2024–2034)

The global Contract Development and Manufacturing Organization (CDMO) services market for pharmaceutical and biotech industries is experiencing significant growth, driven by outsourcing trends, technological advancements, and increasing demand for specialized drug development solutions.

10/31/2025, 10:00 AM • GlobeNewswire